Lung factor is a research group and researcher network that aims in developing better diagnostics and therapeutics to idiopathic pulmonary fibrosis and mesothelioma. These diseases share common molecular pathways. The group involves clinical doctors and basic scientists, that work in close collaboration with the Helsinki Biobank and participates in ie. the FinnGen collaborative effort.
Idiopathic pulmonary fibrosis (IPF)
Mesothelioma and Lung cancer
The research group has started a sample collection together with the Helsinki Biobank with the aim to detect biomarkers for malignant mesothelioma and lung cancer. Mesothelioma is a cancer of the lung sack with high resistance to conventional cancer therapies and a strong association to occupational asbestos exposure. The study has been funded by the Finnish Work Environment Fund, The Helsinki University Hospital, the Finnish Cancer Foundation and the University of Helsinki. For results, please see more from our latest publications.